Join CBSET at the 9th Annual Partnerships in Drug Delivery (PODD) conference, October 7-8, 2019, at the Renaissance Boston Waterfront Hotel, Boston, MA.
This conference is a business development event covering the latest advances in drug delivery science, while also providing a meeting place to network and form new partnerships. The PODD event features a wide range of innovative drug delivery technologies that could potentially improve the delivery of various types of drugs, including proteins, peptides, oligonucleotides, biologics, and small molecules.
CBSET will be exhibiting at this event. If you would like to meet up with us there, contact Rami Tzafriri, CBSET’s Director of Research and Innovation, to schedule a meeting.
Related CBSET Services:
Taking paclitaxel coated balloons to a higher level: Predicting coating dissolution kinetics, tissue retention and dosing dynamics. Abraham R.Tzafriri, Sahil A.Parikh, Elazer R.Edelman. Journal of Controlled Release. Volume 310, 28 September 2019, Pages 94-102.
World Pharma Today, Cell-based Therapy and FDA Review: Partnering for Success at Your pre-IND Meeting
by Michael Naimark, MS, Director of Business Development at CBSET, Inc.
Defining drug and target protein distributions after stent-based drug release: Durable versus deployable coatings. by Tzafriri AR, Garcia-Polite F, Li X, Keating J, Balaguer JM, Zani B, Bailey L, Markham P, Kiorpes TC, Carlyle W, Edelman ER. Journal of Controlled Release, March 28, 2018, Volume 274, Pages 102-108.
Intracochlear Drug Delivery Systems: A Novel Approach Whose Time Has Come. Peppi M, Marie A, Belline C, Borenstein JT. Expert Opinion on Drug Delivery, Volume 15, Issue 4, March 9, 2018, Pages 319-324.
A tunable delivery platform to provide local chemotherapy for pancreatic ductal adenocarcinoma. Indolfi L, Ligorio M, Ting DT, Xega K, Tzafriri AR, Bersani F, Aceto N, Thapar V, Fuchs BC, Deshpande V, Baker AB, Ferrone CR, Haber DA, Langer R, Clark JW, Edelman ER. Biomaterials, Volume 93, July 2016, Pages 71-82.